During the past decade, Dolnoslaskie Centrum Onkologii conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dolnoslaskie Centrum Onkologii" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Ipsen" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored and "Blueprint Medicines Corporation" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dolnoslaskie Centrum Onkologii" #1 collaborator was "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Exelixis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Dolnoslaskie Centrum Onkologii" are "Melanoma" (3 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Advanced/Metastatic Gastroesophageal Adenocarcinoma" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Dolnoslaskie Centrum Onkologii" in a lesser frequency.

Most popular intervention types in "Dolnoslaskie Centrum Onkologii" are "Drug" (17 trials), "Biological" (3 trials), "Other" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Atezolizumab" (4 trials), "Pembrolizumab" (3 trials), "5-FU" (2 trials) and "Capecitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dolnoslaskie Centrum Onkologii" are 18 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Dolnoslaskie Centrum Onkologii". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Dolnoslaskie Centrum Onkologii, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dolnoslaskie Centrum Onkologii, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Dolnoslaskie Centrum Onkologii has several departments that took part in Clinical trials: "Dolnoslaskie Centrum Transplantacji Komorkowych z Krajowym Bankiem Dawcow Szpiku" - 12 trials, "Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii" - 6 trials, "Lower-Silesian Oncology Centre" - 2 trials